ArticleBlood advances2022

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.

Kamal Menghrajani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.